Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

10x Genomics, Inc. (TXG)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income   -142.5-89.1-58.2-455.3-504.0-533.1-542.7
Depreciation and amortization   24.222.621.119.317.215.614.0
Stock-based compensation   115.2105.896.083.371.258.148.6
Change in working capital   [+] -33.9-41.2-43.4-38.2-34.8-38.9-20.4
Other operating activities   -21.2-36.2-36.8233.7263.7279.0282.6
Cash from operations   -58.2-38.1-21.4-157.4-186.8-219.4-217.9
   
Capital expenditures   -103.2-90.5-101.3-95.0-75.3-67.5-36.7
Purchases of intangible assets         -1.7
Acquisitions        -5.5 
Purchases of short-term investments, net   -229.7-229.4     
Cash from investing   -332.9-320.0-106.7-101.4-82.5-74.6-38.4
   
Issuance of common stock, net         482.3
Option exercises   29.839.640.339.937.129.023.7
Financing costs    -5.4   -5.0-5.8
Other cash from financing   48.768.470.669.864.248.04.5
Cash from financing   24.434.235.334.1514.4506.2468.9
   
Free cash flow   -161.4-128.6-122.7-252.4-262.0-286.9-254.6
        Per share (diluted)   ($1.44)($1.16)($1.12)($2.34)($2.49)($2.80)($2.56)
   
Cash paid for interest    0.8   1.2 
Cash paid for income taxes   4.14.78.78.48.07.00.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy